ResearcherChina Medical UniversityNo recent work listed

Xin Meng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7727-6046; OpenAlex author ID A5078039491. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on TCGA and GEO datasets. Co-author DOI 10.1186/s12935-021-01809-y ↗
Development of an autophagy-related signature in pancreatic adenocarcinoma. Last author DOI 10.1016/j.biopha.2020.110080 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Peipei Yue · 2 shared papers, 2020–2021 · strength 0.24
- Paper Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on … DOI 10.1186/s12935-021-01809-y ↗
- Paper Development of an autophagy-related signature in pancreatic adenocarcinoma. DOI 10.1016/j.biopha.2020.110080 ↗
Ji Li · 1 shared paper, 2021 · strength 0.14
- Paper Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on … DOI 10.1186/s12935-021-01809-y ↗
Yao Zhang · 1 shared paper, 2021 · strength 0.14
- Paper Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on … DOI 10.1186/s12935-021-01809-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.